2seventy Bio Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2025 to a ratio of 2.68, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2025. Average receivable collection period, for the 2seventy Bio Inc in Mar 31 2025 quarter, has decreased to 136 days, compared to 145 days, in the Dec 31 2024 quarter.

If we take a look into Healthcare sector 495 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2025 from 3039 to 3301.

What is Receivable Turnover Ratio?
What is 2seventy Bio Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TSVT Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	99.78 %	-41.98 %	14.14 %	-58.9 %	-70.97 %
Y / Y Revenue Change	84.46 %	-72.61 %	12.46 %	-75.12 %	-70.12 %
Receivable Turnover Ratio (TTM)	2.68	2.52	2.77	2.8	3.2
TSVT's Total Ranking	# 3301	# 3039	# 3130	# 2532	# 1748
Accounts Receivable average collection period days	136	145	132	130	114
Seq. Receivable Change	207.52 %	-65.07 %	22.9 %	51.33 %	-10.69 %
Seq. Revenue Change	683.94 %	-78.38 %	50.93 %	-27.89 %	16.39 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 174
Healthcare Sector	# 496
Overall Market	# 3301

Receivable Turnover Ratio Statistics
High	Average	Low
0.21	0.11	0.02
(Sep 30 2023)		(Sep 30 2022)

TSVT Company Profile • Back to TSVT Efficiency Comparisons • Compare TSVT Receivables Turnover Ratio to its Competitors

Financial Statements
2seventy Bio Inc 's Accounts Receivable	$ 24 Millions	Visit TSVT's Balance sheet
2seventy Bio Inc 's Sales TTM	$ 48 Millions	Visit TSVT's Income Statement
Sources of TSVT's Revenues		Visit TSVT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TSVT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TSVT's Growth Rates	TSVT's Roa	TSVT's Inventory Turnover Ratio	TSVT's Dividend Comparisons
TSVT's Profitability Ratios	TSVT's Roi	TSVT's Asset Turnover Ratio	TSVT's Dividend Growth
TSVT's Valuation Ratios	TSVT's Roe	TSVT's Financial Strength Ratios	TSVT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2025	Receivable at quarter ending Mar 31 2025
Opus Genetics Inc	5.54	$ 13.651 Millions	$ 2.465 Millions
West Pharmaceutical Services Inc	5.52	$ 2,895.200 Millions	$ 524.950 Millions
Cryoport inc	5.45	$ 214.833 Millions	$ 39.442 Millions
Neogen Corporation	5.44	$ 904.315 Millions	$ 166.200 Millions
Dariohealth Corp	5.43	$ 26.717 Millions	$ 4.922 Millions
The Cooper Companies Inc	5.40	$ 3,988.800 Millions	$ 738.325 Millions
Tarsus Pharmaceuticals Inc	5.39	$ 233.674 Millions	$ 43.339 Millions
Medtronic Plc	5.39	$ 33,537.000 Millions	$ 6,225.250 Millions
Cue Biopharma Inc	5.38	$ 7.991 Millions	$ 1.486 Millions
Charles River Laboratories International inc	5.37	$ 4,022.597 Millions	$ 748.493 Millions
Clearside Biomedical Inc	5.31	$ 3.764 Millions	$ 0.708 Millions
Avadel Pharmaceuticals Plc	5.31	$ 194.118 Millions	$ 36.539 Millions
Amphastar Pharmaceuticals Inc	5.31	$ 732.497 Millions	$ 137.993 Millions
Rxsight Inc	5.27	$ 147.587 Millions	$ 28.025 Millions
Enovis Corp	5.25	$ 2,148.546 Millions	$ 409.400 Millions
Accuray Incorporated	5.25	$ 464.277 Millions	$ 88.495 Millions
Catheter Precision Inc	5.24	$ 0.481 Millions	$ 0.092 Millions
Xeris Biopharma Holdings Inc	5.23	$ 222.551 Millions	$ 42.581 Millions
Zimmer Biomet Holdings Inc	5.21	$ 7,698.500 Millions	$ 1,478.400 Millions
Vaxart Inc	5.19	$ 47.395 Millions	$ 9.136 Millions
Precision Optics Corporation Inc	5.18	$ 17.626 Millions	$ 3.400 Millions
Evoke Pharma Inc	5.18	$ 11.594 Millions	$ 2.239 Millions
Sonoma Pharmaceuticals Inc	5.18	$ 14.288 Millions	$ 2.760 Millions
Bio techne Corp	5.16	$ 1,218.244 Millions	$ 235.904 Millions
Caredx Inc	5.15	$ 346.421 Millions	$ 67.220 Millions
Exagen Inc	5.11	$ 55.820 Millions	$ 10.913 Millions
Vivos Inc	5.09	$ 0.048 Millions	$ 0.009 Millions
Pfizer Inc	5.08	$ 62,463.000 Millions	$ 12,288.000 Millions
Foxo Technologies Inc	5.06	$ 9.118 Millions	$ 1.801 Millions
Caribou Biosciences Inc	5.06	$ 9.918 Millions	$ 1.959 Millions

Date modified: 2026-08-29T17:46:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.